United Services Automobile Association reduced its holdings in Danaher Co. (NYSE:DHR – Free Report) by 2.1% in the fourth quarter, HoldingsChannel reports. The firm owned 14,738 shares of the conglomerate’s stock after selling 309 shares during the period. United Services Automobile Association’s holdings in Danaher were worth $3,383,000 at the end of the most recent quarter.
Other institutional investors have also recently added to or reduced their stakes in the company. Gilbert & Cook Inc. grew its holdings in Danaher by 2.5% in the 4th quarter. Gilbert & Cook Inc. now owns 1,749 shares of the conglomerate’s stock worth $401,000 after acquiring an additional 42 shares during the last quarter. Grimes & Company Inc. lifted its holdings in Danaher by 0.6% in the 4th quarter. Grimes & Company Inc. now owns 7,390 shares of the conglomerate’s stock worth $1,696,000 after buying an additional 43 shares during the period. Dakota Community Bank & Trust NA increased its stake in shares of Danaher by 16.4% during the fourth quarter. Dakota Community Bank & Trust NA now owns 320 shares of the conglomerate’s stock valued at $73,000 after buying an additional 45 shares during the period. Howard Capital Management Group LLC lifted its stake in Danaher by 4.1% in the third quarter. Howard Capital Management Group LLC now owns 1,229 shares of the conglomerate’s stock worth $342,000 after acquiring an additional 48 shares during the period. Finally, Spinnaker Trust raised its holdings in Danaher by 1.2% in the 4th quarter. Spinnaker Trust now owns 4,304 shares of the conglomerate’s stock worth $988,000 after purchasing an additional 50 shares in the last quarter. 79.05% of the stock is owned by institutional investors and hedge funds.
Insider Transactions at Danaher
In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the transaction, the senior vice president now owns 20,230 shares of the company’s stock, valued at approximately $4,534,149.90. This represents a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 11.10% of the company’s stock.
Analysts Set New Price Targets
View Our Latest Analysis on Danaher
Danaher Price Performance
Shares of NYSE:DHR opened at $211.63 on Monday. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. The firm has a market cap of $151.26 billion, a price-to-earnings ratio of 40.08, a price-to-earnings-growth ratio of 2.66 and a beta of 0.82. The business has a 50-day simple moving average of $217.46 and a two-hundred day simple moving average of $238.50. Danaher Co. has a fifty-two week low of $196.80 and a fifty-two week high of $281.70.
Danaher (NYSE:DHR – Get Free Report) last released its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, meeting the consensus estimate of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same quarter in the previous year, the business earned $2.09 earnings per share. On average, analysts expect that Danaher Co. will post 7.63 earnings per share for the current year.
Danaher Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be issued a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a dividend yield of 0.60%. This is a boost from Danaher’s previous quarterly dividend of $0.27. The ex-dividend date is Friday, March 28th. Danaher’s dividend payout ratio is presently 24.24%.
About Danaher
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Recommended Stories
- Five stocks we like better than Danaher
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- AbbVie Stock Boosts Portfolios With Entry Into Weight Loss Market
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- 3 ETFs to Ride the VIX Surge During Market Volatility
- Stock Dividend Cuts Happen Are You Ready?
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.